CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells

Baker, 2011, NF-kappaB, inflammation, and metabolic disease, Cell Metab., 13, 11, 10.1016/j.cmet.2010.12.008

Donath, 2008, Islet inflammation in type 2 diabetes: from metabolic stress to therapy, Diabetes Care, 31, S161, 10.2337/dc08-s243

Corbett, 1992, Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide, J. Clin. Invest., 90, 2384, 10.1172/JCI116129

Collier, 2011, Pancreatic beta-cell death in response to Pro-inflammatory cytokines is distinct from genuine apoptosis, PLoS One, 6, e22485, 10.1371/journal.pone.0022485

Corbett, 1993, Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans, Proc. Natl. Acad. Sci. U. S. A., 90, 1731, 10.1073/pnas.90.5.1731

Boni-Schnetzler, 2009, Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I, Endocrinology, 150, 5218, 10.1210/en.2009-0543

Burke, 2013, Regulation of iNOS gene transcription by IL-1beta and IFN-gamma requires a coactivator exchange mechanism, Mol. Endocrinol., 27, 1724, 10.1210/me.2013-1159

Sarkar, 2012, Expression and regulation of chemokines in murine and human type 1 diabetes, Diabetes, 61, 436, 10.2337/db11-0853

Burke, 2014, NF-kappaB and STAT1 control CXCL1 and CXCL2 gene transcription, Am. J. Physiol. Endocrinol. Metab., 306, E131, 10.1152/ajpendo.00347.2013

Burke, 2013, Synergistic expression of the CXCL10 gene in response to IL-1beta and IFN-gamma involves NF-kappaB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4, J. Immunol., 191, 323, 10.4049/jimmunol.1300344

Burke, 2012, Regulation of the CCL2 gene in pancreatic beta-cells by IL-1beta and glucocorticoids: Role of MKP-1, PLoS One, 7, e46986, 10.1371/journal.pone.0046986

Tilstra, 2011, NF-kappaB in aging and disease, Aging Dis., 2, 449

Brown, 2008, The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis, Arthritis Res. Ther., 10, 212, 10.1186/ar2457

Ben-Neriah, 2011, Inflammation meets cancer, with NF-kappaB as the matchmaker, Nat. Immunol., 12, 715, 10.1038/ni.2060

Cai, 2013, Neuroinflammation and neurodegeneration in overnutrition-induced diseases, Trends Endocrinol. Metab., 24, 40, 10.1016/j.tem.2012.11.003

Oeckinghaus, 2011, Crosstalk in NF-kappaB signaling pathways, Nat. Immunol., 12, 695, 10.1038/ni.2065

Beg, 1993, The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors, Genes Dev., 7, 2064, 10.1101/gad.7.11.2064

Gerard, 2001, Chemokines and disease, Nat. Immunol., 2, 108, 10.1038/84209

Weisberg, 2006, CCR2 modulates inflammatory and metabolic effects of high-fat feeding, J. Clin. Invest., 116, 115, 10.1172/JCI24335

Kim, 2006, Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters, Int. J. Obes., 30, 1347, 10.1038/sj.ijo.0803259

Martin, 2008, Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes, Diabetes, 57, 3025, 10.2337/db08-0625

Cowley, 2012, Human islets express a marked proinflammatory molecular signature prior to transplantation, Cell Transplant., 21, 2063, 10.3727/096368911X627372

Merani, 2006, Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction, Cell Transplant., 15, 295, 10.3727/000000006783981963

Citro, 2012, CXCR1/2 inhibition enhances pancreatic islet survival after transplantation, J. Clin. Invest., 122, 3647, 10.1172/JCI63089

Hromas, 1997, Cloning and characterization of exodus, a novel beta-chemokine, Blood, 89, 3315

Matsui, 2001, Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis, Clin. Exp. Immunol., 125, 155, 10.1046/j.1365-2249.2001.01542.x

Jafarzadeh, 2014, Higher circulating levels of chemokine CCL20 in patients with multiple sclerosis: Evaluation of the influences of chemokine gene polymorphism, gender, treatment and disease pattern, J. Mol. Neurosci., 53, 500, 10.1007/s12031-013-0214-2

Sato, 2001, Chemokine receptor expressions and responsiveness of cord blood T cells, J. Immunol., 166, 1659, 10.4049/jimmunol.166.3.1659

Christopherson, 1999, Regulation of naive fetal T-cell migration by the chemokines Exodus-2 and Exodus-3, Immunol. Lett., 69, 269, 10.1016/S0165-2478(99)00099-1

Kucharzik, 2002, CCR6 expression distinguishes mouse myeloid and lymphoid dendritic cell subsets: demonstration using a CCR6 EGFP knock-in mouse, Eur. J. Immunol., 32, 104, 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C

Brandes, 2000, Activation-dependent modulation of B lymphocyte migration to chemokines, Int. Immunol., 12, 1285, 10.1093/intimm/12.9.1285

Krzysiek, 2000, Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells, Blood, 96, 2338, 10.1182/blood.V96.7.2338

Robertson, 2000, Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines, Cell. Immunol., 199, 8, 10.1006/cimm.1999.1601

Diana, 2013, Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes, Nat. Med., 19, 65, 10.1038/nm.3042

Battaglia, 2014, Neutrophils and type 1 autoimmune diabetes, Curr. Opin. Hematol., 21, 8, 10.1097/MOH.0000000000000008

Valle, 2013, Reduction of circulating neutrophils precedes and accompanies type 1 diabetes, Diabetes, 62, 2072, 10.2337/db12-1345

Hohmeier, 2000, Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion, Diabetes, 49, 424, 10.2337/diabetes.49.3.424

Janjic, 1999, Free radical modulation of insulin release in INS-1 cells exposed to alloxan, Biochem. Pharmacol., 57, 639, 10.1016/S0006-2952(98)00346-3

Collier, 2006, Pro- and antiapoptotic proteins regulate apoptosis but do not protect against cytokine-mediated cytotoxicity in rat islets and beta-cell lines, Diabetes, 55, 1398, 10.2337/db05-1000

Markert, 1984, Measurement of O2- production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils, Methods Enzymol., 105, 358, 10.1016/S0076-6879(84)05048-5

Donath, 2010, Cytokine production by islets in health and diabetes: cellular origin, regulation and function, Trends Endocrinol. Metab., 21, 261, 10.1016/j.tem.2009.12.010

McGillicuddy, 2011, Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis, Diabetes, 60, 1688, 10.2337/db10-1278

Jobin, 1998, Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells, J. Immunol., 160, 410, 10.4049/jimmunol.160.1.410

Ueda, 1994, NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene, J. Immunol., 153, 2052, 10.4049/jimmunol.153.5.2052

Newton, 1997, Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta, Biochem. Biophys. Res. Commun., 237, 28, 10.1006/bbrc.1997.7064

Moorthy, 2006, The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner, EMBO J., 25, 1945, 10.1038/sj.emboj.7601081

Medzhitov, 2009, Transcriptional control of the inflammatory response, Nat. Rev. Immunol., 9, 692, 10.1038/nri2634

Covic, 2005, Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression, EMBO J., 24, 85, 10.1038/sj.emboj.7600500

Vo, 2001, CREB-binding protein and p300 in transcriptional regulation, J. Biol. Chem., 276, 13505, 10.1074/jbc.R000025200

Olza, 2012, Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children, Diabetes Care, 35, 2373, 10.2337/dc12-0614

Guo, 2013, Inactivation of specific beta cell transcription factors in type 2 diabetes, J. Clin. Invest., 123, 3305, 10.1172/JCI65390

Li, 2014, Islet antigen-specific Th17 cells can induce TNF-alpha-dependent autoimmune diabetes, J. Immunol., 192, 1425, 10.4049/jimmunol.1301742

Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183

Dinarello, 2010, Role of IL-1beta in type 2 diabetes, Curr. Opin. Endocrinol. Diabetes Obes., 17, 314, 10.1097/MED.0b013e32833bf6dc

Rabinovitch, 1995, IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice, J. Immunol., 154, 4874, 10.4049/jimmunol.154.9.4874

Boni-Schnetzler, 2008, Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation, J. Clin. Endocrinol. Metab., 93, 4065, 10.1210/jc.2008-0396

Maedler, 2002, Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets, J. Clin. Invest., 110, 851, 10.1172/JCI200215318

Grant, 2015, Adipose tissue as an immunological organ, Obesity (Silver Spring), 23, 512, 10.1002/oby.21003

Grant, 2013, Mechanisms of disease: inflammasome activation and the development of type 2 diabetes, Front. Immunol., 4, 50, 10.3389/fimmu.2013.00050

Cnop, 2014, RNA sequencing identifies dysregulation of the human pancreatic islet transcriptome by the saturated fatty acid palmitate, Diabetes, 63, 1978, 10.2337/db13-1383

Atkinson, 2014, Type 1 diabetes, Lancet, 383, 69, 10.1016/S0140-6736(13)60591-7

Donath, 2011, Type 2 diabetes as an inflammatory disease, Nat. Rev. Immunol., 11, 98, 10.1038/nri2925

Yeung, 2012, Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile, Diabetes, 61, 1500, 10.2337/db11-0264

Perez, 2004, Plasma levels of interleukin-1beta, interleukin-2 and interleukin-4 in recently diagnosed type 1 diabetic children and their association with beta-pancreatic autoantibodies, Rev. Med. Chil., 132, 413

van Poppel, 2014, The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance, Diabetes Obes. Metab., 16, 1269, 10.1111/dom.12357

van Asseldonk, 2011, Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study, J. Clin. Endocrinol. Metab., 96, 2119, 10.1210/jc.2010-2992

Larsen, 2007, Interleukin-1-receptor antagonist in type 2 diabetes mellitus, N. Engl. J. Med., 356, 1517, 10.1056/NEJMoa065213

Coppieters, 2012, Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients, J. Exp. Med., 209, 51, 10.1084/jem.20111187

Duffaut, 2009, Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators, Arterioscler. Thromb. Vasc. Biol., 29, 1608, 10.1161/ATVBAHA.109.192583

Mackay, 2008, Moving targets: cell migration inhibitors as new anti-inflammatory therapies, Nat. Immunol., 9, 988, 10.1038/ni.f.210

Liston, 2009, Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response, J. Immunol., 182, 3121, 10.4049/jimmunol.0713169

Honkanen, 2010, IL-17 immunity in human type 1 diabetes, J. Immunol., 185, 1959, 10.4049/jimmunol.1000788

Schulthess, 2009, CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling, Cell Metab., 9, 125, 10.1016/j.cmet.2009.01.003

Oshima, 2006, Destruction of pancreatic beta-cells by transgenic induction of prostaglandin E2 in the islets, J. Biol. Chem., 281, 29330, 10.1074/jbc.M602424200